Resource Library

Search All Resources

  • Clear All
HCV and People Who Inject Drugs | May 27, 2020

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #Antagonist Treatment  #injection drugs  #Methamphetamine Use Disorder  #Mirtazapine  #opioid use disorder  

Dr. Jessica Gregg, Associate Professor of Medicine at OHSU, shares information on HCV in people who inject drugs, and medications used to treat opioid use disorder.

Date added: 05/27/20

COVID-19 Infection and the Liver | April 14, 2020

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #covid and the liver  #liver disease  

Dr. Brian McMahon, Director of the Liver Disease and Hepatitis Program at the Alaska Native Tribal Health Consortium, talks about the differences in the underlying structure and pathogenicity of the different strains of coronavirus, how COVID-19 can involve the liver, ...

Date added: 04/14/20

COVID-19 | March 25, 2020

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #covid clinical updates  #covid-19  

Dr. Jorge Mera, Director of Infectious Diseases for Cherokee Nation Health Service, and Whitney Essex, Family Nurse Practitioner for Cherokee Nation Health Service, provide an overview on the epidemiology of COVID-19, share clinical examples and discuss potential treatments.

Date added: 03/25/20

Surveillance To Detect Hepatocellular Carcinoma | March 12, 2019

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hepatocellular carcinoma  #hepatology  #liver disease  #liver screening  

Incidence of hepatocellular carcinoma (HCC) is rising quickly in the United States, and AI/AN people are being affected greater than any other group. Dr. Brian McMahon, Director of the Liver Disease and Hepatitis Program at the Alaska Native Tribal Health ...

Date added: 03/12/19

Addressing the Evolving Opioid and HCV Epidemics | February 27, 2019

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #harm reduction  #hcv and opioids  #injection drugs  

Annette Hewitt, Nurse Practitioner for the Liver Disease and Hepatitis Program at the Alaska Native Tribal Health Consortium, explains parallels between the opioid and HCV epidemics. She also discusses harm reduction strategies that may be helpful and emphasizes the importance ...

Date added: 02/27/19

Addiction Treatment and the HCV Provider | February 12, 2019

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hcv and opioids  

Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, discusses the relationship between the opioid epidemic and HCV infections as well as the different treatments available for those suffering from opioid use disorder.

Date added: 02/12/19

HCV Elimination | January 23, 2019

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #cherokee hcv elimination  #hcv elimination  #micro-elimination  

Dr. Jorge Mera, Director of Infectious Diseases for the Cherokee Nation Health Service, provides a general overview of HCV elimination and micro-elimination, as well as an overview of the Cherokee Nation HCV Elimination Program.

Date added: 01/23/19

The Impact of SVR on Cirrhosis and Non-Liver Complications | December 11, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #cirrhosis  #direct acting antiviral  #interferon treatment  #liver disease  #sustained virologic response  

Annette Hewitt and Lisa Townshend-Bulson, Family Nurse Practitioners from the Alaska Native Tribal Health Consortium, Liver Disease & Hepatitis Program, present on the impact of sustained virologic response (SVR) on cirrhosis and non-liver complications in both direct acting antiviral (DAA) ...

Date added: 12/11/18

Opioid Substitution Therapy and the HCV-Provider | November 28, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hcv and opioids  #opioid substitution therapy  #opioids  

Dr. Aaron Skiles, a Family Nurse Practitioner with the UNM Sandoval Regional Medical Center, shares knowledge on the opioid epidemic, the merits of opioid substitution therapy, and the role of the HCV care provider in treating opioid use disorder.

Date added: 11/28/18

HCV in Pregnant Women: How the Opioid Crisis is Changing the Landscape | September 26, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hcv and children  #hcv and opioids  #hcv and pregnancy  #maternal child health  #opioids  

Dr. Francheska Sevy Gurule, a Maternal Child Health Fellow at the University of New Mexico, Department of Family and Community Medicine, presents on the impact the opioid crisis has had on the prevalence of HCV in pregnant women.

Date added: 09/26/18